NWPF

Search Results Tagged With Parkinsons Medical Therapy

Spinal Cord Stimulation Protects Against Parkinson's Symptoms

https://nwpf.org/stay-informed/news/2014/01/spinal-cord-stimulation-protects-against-parkinsons-symptoms/

In a study conducted on rodents, researchers at Duke Medicine discovered that spinal cord stimulation helps in temporarily easing the symptoms of Parkinson's disease, a progressive neurological disord…
January 30, 2014

Tiny cellular bubbles enable delivery of Parkinson's drugs straight to the brain

https://nwpf.org/stay-informed/news/2015/05/tiny-cellular-bubbles-enable-delivery-of-parkinson’s-drugs-straight-to-the-brain/

Cellular bubbles (exosomes) that are extracted from human immune cells could deliver catalase (an enzyme that proves to be an effective treatment) to pass through brain’s defense and therefore to opti…
May 05, 2015

Parkinson's could be slowed with existing drug

https://nwpf.org/stay-informed/news/2015/08/parkinsons-could-be-slowed-with-existing-drug/

Researchers have discovered a drug that has long been used to treat liver disease could also be used to slow down the effects of Parkinson's disease.
August 10, 2015

Exoskeleton Could Quell the Tremors of Parkinson's Disease Patients at Crucial Moments

https://nwpf.org/stay-informed/news/2016/06/life-with-parkinson’s-disease-made-better-by-program/

Parkinson’s disease brings on the shakes, and these tremors often get worse as the disease progresses. To prevent this symptom from interfering with patients’ daily lives, researchers in London have d…
June 29, 2016

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

https://nwpf.org/stay-informed/news/2016/02/new-clinical-trial-focuses-on-respiratory-drug-ambroxol-for-treatment-of-parkinsons-disease/

A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson's disease.
February 23, 2016

AbbVie Announces U.S. FDA Approval of DUOPA™ Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease

https://nwpf.org/stay-informed/news/2015/03/abbvie-announces-us-fda-approval-of-duopa™/

DUOPA is a new approach to the administration of carbidopa and levodopa for the treatment of motor fluctuations for people with advanced Parkinson's disease.
March 19, 2015

Deep Brain Stimulation May Ease Some Parkinson's Pain for Years

https://nwpf.org/stay-informed/news/2015/03/deep-brain-stimulation-may-ease-some-parkinsons-pain-for-years/

People with Parkinson's disease who undergo deep brain stimulation may experience long-term pain relief, a small, new study from Korea suggests. However, three-quarters of the patients developed new p…
March 23, 2015

Hopes of vaccine for Parkinson’s sufferers

https://nwpf.org/stay-informed/news/2015/04/hopes-of-vaccine-for-parkinson’s-sufferers/

Toxins such as "prions" which could be one of the causes of Parkinson's development could be obstructed by vaccine.
April 25, 2015

FDA lifts clinical hold on NeuroDerm's ND0612 to treat Parkinson's disease

https://nwpf.org/stay-informed/news/2015/05/fda-lifts-clinical-hold-on-neuroderms-nd0612-to-treat-parkinsons-disease/

The US Food and Drug Administration (FDA) has lifted the clinical hold on Israeli pharmaceutical firm NeuroDerm's US clinical studies of its primary product candidates, ND0612H and ND0612L, which are …
May 11, 2015

Low-dose lithium reduces side effects from most common treatment for Parkinson's disease

https://nwpf.org/stay-informed/news/2015/07/low-dose-lithium-reduces-side-effects-from-most-common-treatment-for-parkinsons-disease/

Low-dose lithium reduced involuntary motor movements - the troubling side effect of the medication most commonly used to treat Parkinson's disease (PD) - in a mouse model of the condition that is diag…
July 27, 2015

<< Back 1 - 10 of 14 Next >>